PACS Stock PACS Group (PACS, $44.32) was a top quarterly gainer, rising +37.9%
at Tickeron.com
Loading...
PACS Group (PACS, $44.32) was one of top quarterly gainers, jumping to $44.32 per share. A.I.dvisor analyzed 51 stocks in the Hospital/Nursing Management Industry over the last three months, and discovered that of them (8) charted an Uptrend while of them (1) trended down.
PACS in +1.53% Uptrend, growing for three consecutive days on July 06, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PACS advanced for three days, in of 112 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 22, 2026. You may want to consider a long position or call options on PACS as a result. In of 31 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PACS just turned positive on June 22, 2026. Looking at past instances where PACS's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .
PACS moved above its 50-day moving average on June 18, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PACS crossed bullishly above the 50-day moving average on June 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 104 cases where PACS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for PACS moved out of overbought territory on July 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 21 cases where PACS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PACS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PACS broke above its upper Bollinger Band on July 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PACS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.605) is normal, around the industry mean (224.603). P/E Ratio (27.916) is within average values for comparable stocks, (122.974). Projected Growth (PEG Ratio) (1.274) is also within normal values, averaging (2.564). PACS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (1.248) is also within normal values, averaging (2.591).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PACS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.